Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma

British Journal of Dermatology

Volumn 150, Issue 2, 2004, Pages 179-185

  Lens, M B ^a   Dawes, M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Aetiology; Incidence; Melanoma; Mortality

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE N2A; PROTEIN P16; UNCLASSIFIED DRUG;

AGE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CARCINOGENESIS; CAUCASIAN; CHROMOSOME 12; CHROMOSOME 9; EDUCATION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; LIFESTYLE; LUNG CANCER; MELANOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SKIN CANCER; SUNLIGHT; TESTIS CANCER; ULTRAVIOLET RADIATION;

FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; RISK FACTORS; SEX DISTRIBUTION; SKIN NEOPLASMS; WORLD HEALTH;

EID: 1542611579     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05708.x     Document Type: Review

References (42)

1. Dlepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146 (Suppl. 61): 1-6.
2. Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000; 89: 1269-78.
3. World Health Organization, GLOBOCAN: Cancer Incidence, Mortality and Prevalence Worldwide, IARC Cancerbase No. 5, Version 1.0. Lyon: IARC. 2001.
4. AIHW. Australian Health Trends 2001. Canberra: Australian Institute of Health and Welfare, 2001.
5. MacLennan R, Green AC, McLeod GR, Martin NG. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 1992; 84: 1427-32.
6. Burton RC, Coates MS, Hersey P et al. An analysis of melanoma epidemic. Int J Cancer 1993; 55: 765-70.
7. Burton RC. Malignant melanoma in the year 2000. CA Cancer J Clin 2000; 50: 209-13.
8. Czarnecki D, Meehan CJ. Is the incidence of malignant melanoma decreasing in young Australians? J Am Acad Dermatol 2000; 42: 672-4.
9. Jones WO, Harman R, Ng AK, Shaw JH. Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world. World J Surg 1999; 23: 732-5.
10. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001; 93: 678-83.
11. National Cancer Institute, DCCPS, Surveillance Research Program. Cancer Statistics Branch, Surveillance, Epidemiology, and End Results (SEER) Program. http://www.seer.cancer.gov. 2003.
12. Rigel DS. The effect of sunscreen on melanoma risk. Dermatol Clin 2002; 20: 601-6.
13. Jemal A, Murray T, Samuels A et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26.
14. Bulliard JL, Cox B, Semenciw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control 1999; 10: 407-16.
15. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001; 14: 280-90.
16. Centre for Epidemiology, The Swedish Cancer Registry, Cancer Incidence in Sweden 2000. Stockholm, Sweden: The National Board of Health and Welfare, 2000.
17. Thorn M, Ponten F, Johansson AM, Bergstrom R. Rapid increase in diagnosis of cutaneous melanoma in situ in Sweden, 1968-1992. Cancer Detect Prev 1998; 22: 430-7.
18. Mansson-Brahme E, Johansson H, Larsson O et al. Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994. Acta Oncol 2002; 41: 138-46.
19. Vinceti M, Bergomi M, Borciani N et al. Rising melanoma incidence in an Italian community from 1986 to 1997. Melanoma Res 1999; 9; 97-103.
20. Office for National Statistics. http://www.stattstics.gov.uk, 2003.
21. MacKie RM, Bray CA, Hole DJ et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 2002; 360: 587-91.
22. Holme SA, Malinovsky K, Roberts DL. Malignant melanoma in South Wales: changing trends in presentation (1986-98). Clin Exp Dermatol 2001; 26: 484-9.
23. MacKie RM. Incidence, risk factors and prevention of melanoma. Eur J Cancer 1998; 34 (Suppl. 3): S3-6.
24. Brochez L, Naeyaert JM. Understanding the trends in melanoma incidence and mortality: where do we stand? Eur J Dermatol 2000; 10: 71-5.
25. Marks R. Epidemiology of melanoma. Clin Exp Dermatol 2000; 25: 459-63.
26. La Vecchia C, Lucchini F, Negri E et al. Recent trends in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999; 81: 62-6.
27. Severi G, Giles GG, Robertson C et al. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000; 82: 1887-91.
28. Streetly A, Markowe H. Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol 1995; 24: 897-907.
29. Giles GG, Armstrong BK, Burton RC et al. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. Br Med J 1996; 312: 1121-5.
30. Marks R. The changing incidence and mortality of melanoma in Australia. Recent Results Cancer Res 2002; 160: 113-21.
31. Howe HL, Wingo PA, Thun MJ et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001; 93: 824-42.
32. Bleyen L. De Bacquer D, Myny K et al. Trends in mortality from cutaneous malignant melanoma in Belgium. Int J Epidemiol 1999; 28: 40-5.
33. Nieto A, Ruiz-Ramos M, Abdel-Kader L et al. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98. Br J Dermatol 2003; 148: 110-16.
34. Ortonne JP. Photobiology and genetics of malignant melanoma. Br J Dermatol 2002: 146 (Suppl. 61): 11-16.
35. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiological studies. Cancer Causes Control 2001; 12: 69-82.
36. Berwick M. Patterns of sun exposure which are causal for melanoma. In: Melanoma. Critical Debates (Newton Bishop JA, Gore M, eds). Oxford: Blackwell Science, 2002; 3-15.
37. Bastuji-Garin S, Diepgen TL. Cutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence. Br J Dermatol 2002; 146 (Suppl. 61): 24-30.
38. Swerdlow AJ, Weinstock MA. Do tanning lamps cause melanoma? An epidemiological assessment. J Am Acad Dermatol 1998; 38: 89-98.
39. MacLennan R, Kelly JW, Rivers JK, Harrison SL. The Eastern Australian Childhood Nevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. J Am Acad Dermatol 2003; 48: 367-75.
40. Goldstein AM, Tucker MA, Genetic epidemiology of cutaneous melanoma. A global perspective. Arch Dermatol 2001; 137: 1493-6.
41. Bishop DT, Demenais F, Goldstein AM et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002; 94: 894-903.
42. Kefford R, Bishop JN, Tucker M et al. Genetic testing for melanoma. Lancet Oncol 2002; 3: 653-4.